NasdaqCM - Delayed Quote USD
Lipocine Inc. (LPCN)
2.8700
-0.0500
(-1.71%)
At close: May 13 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 157.84k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| PATEL MAHESH V Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 8, 2024 |
| FOGARTY KRISTA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 8, 2024 |
| PATEL MAHESH V Chief Executive Officer | Purchase at price 5.03 per share. | Direct | 43,791 | May 25, 2023 |
Related Tickers
GRCE Grace Therapeutics, Inc.
2.6000
-4.41%
CNTB Connect Biopharma Holdings Limited
0.7610
-5.17%
MIST Milestone Pharmaceuticals Inc.
1.1900
-0.83%
IOBT IO Biotech, Inc.
1.0000
-2.91%
ATRA Atara Biotherapeutics, Inc.
6.68
+3.25%
XFOR X4 Pharmaceuticals, Inc.
3.3100
-0.90%
IRD Opus Genetics, Inc.
0.9592
+0.97%
VNDA Vanda Pharmaceuticals Inc.
3.9800
-1.24%
CGTX Cognition Therapeutics, Inc.
0.3212
-1.74%
VTGN Vistagen Therapeutics, Inc.
2.3700
+2.16%